News from the healthcare data industry
CHICAGO, June 2, 2022 /PRNewswire/ — EVERSANA™, a pioneer of next-generation commercial services to the global life sciences industry, and Limitless Minds™, a business and wellness coaching firm founded by professional athlete Russell Wilson and co-founders Trevor Moawad, Harrison Wilson,...
June 02, 2022 06:59 AM Eastern Daylight Time DENVER–(BUSINESS WIRE)–Palantir Technologies Inc. (NYSE:PLTR) announced today that the U.S. Space Systems Command (SSC) Battle Management Command, Control, and Communications (BMC3) awarded...
By Brittany Wade June 2, 2022 | Innovation Practices Award–Extracting high-quality data from clinical records can be time-consuming and costly, primarily when manual abstractors are tasked with mining complex, unstructured, and...
Members of CDRC will be able to utilize xCures’ technology to quickly abstract and structure clinical data to support drug repurposing studies in rare cancer. This partnership will enable CDRC...
Austin, Texas—June 1, 2022 Today, Oracle Corporation (NYSE: ORCL) announced that all required antitrust approvals have been obtained for its proposed acquisition of Cerner, including European Commission clearance. Cerner is...
Jeffrey D Horn,1 Bret L Fisher,2 Daniel Terveen,3 Helene Fevrier,4 Mohinder Merchea,5 Xiaolin Gu5 1Vision for Life, Nashville, TN, USA; 2Eye Center of North Florida, Panama City, FL, USA; 3Vance Thompson Vision, Sioux Falls, SD, USA; 4Verana Health,...
Mountain View, California, June 01, 2022 (GLOBE NEWSWIRE) — Health Gorilla, a leading Health Information Network (HIN) and interoperability provider, has announced a partnership with Apricity Health, a provider of cutting-edge applications...
ollaboration Will Provide Galleri Test to 10,000 Veterans Across the U.S. Over the Next Three Years; VA Pittsburgh Healthcare System Announced as First of Approximately 10 Participating Sites Collaboration is...
Key data reinforce the utility of Foundation Medicine’s tissue- and blood-based comprehensive genomic profiling to support treatment planning, and demonstrate the value of real-world genomic data to facilitate equitable research...
NEW YORK – It’s been three years since the US Food and Drug Administration agreed Janssen’s Balversa (erdafitinib) for patients with advanced bladder tumors harboring FGFR3 or FGFR2 gene alterations, however a...